DKK1 and posterior cortical atrophy: A parallel arm Phase 1b/IIa study of DKN-01, a DKK1 inhibitor, as a monotherapy or in combination with docetaxel in patients with advanced PCa and elevated DKK-1 levels is underway (NCT03837353).